Investment banking firm Jefferies raises Eli Lilly's price target based on optimism over orfoscerinib, indicating strong confidence in its potential. ...
Stocks have been experiencing unusual volatility after earnings reports, sparking concerns about a possible pullback in the market. Experts predict ...